![TYME Announces Orphan Drug Designation for Potential Pancreatic Cancer Treatment - New Jersey Business Magazine TYME Announces Orphan Drug Designation for Potential Pancreatic Cancer Treatment - New Jersey Business Magazine](https://njbmagazine.com/wp-content/uploads/2020/08/medication-775x500.jpeg)
TYME Announces Orphan Drug Designation for Potential Pancreatic Cancer Treatment - New Jersey Business Magazine
![Cells | Free Full-Text | Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance Cells | Free Full-Text | Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance](https://pub.mdpi-res.com/cells/cells-11-02952/article_deploy/html/images/cells-11-02952-ag.png?1663845299)
Cells | Free Full-Text | Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
![Researchers find tumor microbiome interactions may identify new approaches for pancreatic cancer treatment - Microbiome Times Magazine Researchers find tumor microbiome interactions may identify new approaches for pancreatic cancer treatment - Microbiome Times Magazine](https://www.microbiometimes.com/wp-content/uploads/2022/10/shutterstock_2079075337-678x381.jpg)
Researchers find tumor microbiome interactions may identify new approaches for pancreatic cancer treatment - Microbiome Times Magazine
![Microorganisms in Tumors May Help Identify New Approaches for Treating Pancreatic Cancer | Rutgers University Microorganisms in Tumors May Help Identify New Approaches for Treating Pancreatic Cancer | Rutgers University](https://www.rutgers.edu/sites/default/files/cancer.gif)
Microorganisms in Tumors May Help Identify New Approaches for Treating Pancreatic Cancer | Rutgers University
![RenovoRx Enrolls First Pancreatic Cancer Patient at Columbia University's New York-Presbyterian Hospital Irving Medical Center in Ongoing TIGeR-PaC Phase 3 Clinical Trial - RenovoRx RenovoRx Enrolls First Pancreatic Cancer Patient at Columbia University's New York-Presbyterian Hospital Irving Medical Center in Ongoing TIGeR-PaC Phase 3 Clinical Trial - RenovoRx](https://renovorx.com/wp-content/uploads/2021/05/Renovo-RX-Cateter-Scene-Pancreas-with-chemo-with-catheter-v2CMYK.jpg)
RenovoRx Enrolls First Pancreatic Cancer Patient at Columbia University's New York-Presbyterian Hospital Irving Medical Center in Ongoing TIGeR-PaC Phase 3 Clinical Trial - RenovoRx
![Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015 - Lu - 2022 - Cancer Medicine - Wiley Online Library Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015 - Lu - 2022 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f31ca349-ef43-427a-a702-35d7dead800c/cam44610-toc-0001-m.jpg?trick=1699188296428)
Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015 - Lu - 2022 - Cancer Medicine - Wiley Online Library
![Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value - ScienceDirect Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2329050123000712-fx1.jpg)